menu
    • menu

    Company profile for Vallon Pharmaceuticals

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vallon Pharmaceuticals focuses on the development and commercialization of novel treatments for CNS disorders. We are currently focused on the development and commercialization of a novel treatment for ADHD and Narcolepsy where there is substantial unmet need. Vallon began conducting clinical trials of ADAIR in mid-2018. If clinical trials are successful, Vallon will seek marketing approval for the product from national regula...
    Vallon Pharmaceuticals focuses on the development and commercialization of novel treatments for CNS disorders. We are currently focused on the development and commercialization of a novel treatment for ADHD and Narcolepsy where there is substantial unmet need. Vallon began conducting clinical trials of ADAIR in mid-2018. If clinical trials are successful, Vallon will seek marketing approval for the product from national regulatory bodies including the FDA. Vallon intends to develop multiple products using its patented abuse deterrent technology.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vallon PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    100 N. 18th Street, Suite 300 Philadelphia, PA 19103
    Telephone
    Telephone
    (267) 207-3606
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vallon-pharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vallon-pharmaceuticals-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/VallonPharma

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vallon Pharmaceuticals Completes Merger with GRI Bio, Inc.
    Vallon Pharmaceuticals Completes Merger with GRI Bio, Inc.

    21 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/21/2652134/0/en/Vallon-Pharmaceuticals-Completes-Merger-with-GRI-Bio-Inc.html

    GLOBENEWSWIRE
    21 Apr 2023
    Share Share
    Vallon Pharmaceuticals Announces Stockholder Approval of Merger with GRI Bio
    Vallon Pharmaceuticals Announces Stockholder Approval of Merger with GRI Bio

    20 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/20/2651660/0/en/Vallon-Pharmaceuticals-Announces-Stockholder-Approval-of-Merger-with-GRI-Bio-Inc-and-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    20 Apr 2023
    Share Share
    Vallon Pharma Adjourns Special Meeting of Stockholders Until April 20, 2023
    Vallon Pharma Adjourns Special Meeting of Stockholders Until April 20, 2023

    12 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/12/2645721/0/en/Vallon-Pharmaceuticals-Adjourns-Special-Meeting-of-Stockholders-Until-April-20-2023.html

    GLOBENEWSWIRE
    12 Apr 2023
    Share Share
    Vallon Provides an Update on Proxy Voting for the Proposed Merger with GRI Bio
    Vallon Provides an Update on Proxy Voting for the Proposed Merger with GRI Bio

    04 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/04/2640773/0/en/Vallon-Pharmaceuticals-Provides-an-Update-on-Proxy-Voting-for-the-Proposed-Merger-with-GRI-Bio-and-Urges-Stockholders-of-Record-as-of-March-6-2023-to-Vote-by-April-11-2023-at-11-59.html

    GLOBENEWSWIRE
    04 Apr 2023
    Share Share
    Vallon Pharmaceuticals Reports Fiscal Year 2022 Financial Results
    Vallon Pharmaceuticals Reports Fiscal Year 2022 Financial Results

    24 Feb 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/02/24/2615171/0/en/Vallon-Pharmaceuticals-Reports-Fiscal-Year-2022-Financial-Results.html

    GLOBENEWSWIRE
    24 Feb 2023
    Share Share
    Vallon and GRI Bio to Present at Investor 2023 Companies to Watch Event
    Vallon and GRI Bio to Present at Investor 2023 Companies to Watch Event

    11 Jan 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/01/11/2587096/0/en/Vallon-Pharmaceuticals-and-GRI-Bio-to-Present-at-the-Virtual-Investor-2023-Companies-to-Watch-Event.html

    GLOBENEWSWIRE
    11 Jan 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search